Grant: CIHR - ICR / Cancer Research Society Partnership - Research Grants
University of Alberta
$62,350.00
Exploring bone health in cancer immunotherapy survivors
EF 2022-23
Résumé
Immune checkpoint inhibitors(ICI) are a new class of drugsthat have revolutionized cancer treatment. ICI works by activating the immune system to kill cancer cells. However, activating the immune system can lead to activation of osteoclasts, which are cellsthat eat away bone, leading to a disease called osteoporosis which increases a person’srisk of breaking their bones with minimal trauma. This potential risk of ICI treatment has not been studied, but can seriously impact cancer survivors' quality of life. In this project, we will examine the effects of ICI on bone health and risk of bone fractures. These results may lead to waysto reduce bone loss and prevent fracturesin ICI survivors, leading to improved quality of life
Programme
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
488249
Name
Ye Carrie
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Exploring bone health in cancer immunotherapy survivors
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$62,350
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Keyworddelim
Decreasing Secondary Effects Of Treatment; Immunotherapy
Abstract
Immune checkpoint inhibitors(ICI) are a new class of drugsthat have revolutionized cancer treatment. ICI works by activating the immune system to kill cancer cells. However, activating the immune system can lead to activation of osteoclasts, which are cellsthat eat away bone, leading to a disease called osteoporosis which increases a person’srisk of breaking their bones with minimal trauma. This potential risk of ICI treatment has not been studied, but can seriously impact cancer survivors' quality of life. In this project, we will examine the effects of ICI on bone health and risk of bone fractures. These results may lead to waysto reduce bone loss and prevent fracturesin ICI survivors, leading to improved quality of life
Competitiondate
202302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ye, Carrie
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $62,350~ $0~